Skip to content
Use caution Medical device recall · FDA · Published October 14, 2019

Becton Dickinson Posiflush Syringes Recall: Mixing Risk with Human Use Labels

Becton Dickinson recalls Canadian BD Posiflush Pre-Filled Normal Saline Syringes (Catalog 306575) due to risk of mixing with non-human-use syringes. Affected units have specific labels and lot numbers.

🇺🇸 FDA recall #Z-0500-2020Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Company1 Becton Dr · Franklin Lakes, NJ 07417-1815
✎ GovInfoNow plain-language explainer

What happened, in plain English

Becton Dickinson is recalling certain Canadian Posiflush syringes that may mix with non-human-use syringes. This mixing could cause incorrect use in medical settings, potentially leading to patient harm. Read more at govinfonow.com/recall/66790-becton-dickinson-posiflush-syringes-recall-mixing-risk-with-human-use.

Source Summary by GovInfoNow · govinfonow.com/recall/66790-becton-dickinson-posiflush-syringes-recall-mixing-risk-with-human-use · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0500-2020

Cite this page

“Becton Dickinson Posiflush Syringes Recall: Mixing Risk with Human Use Labels.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/66790-becton-dickinson-posiflush-syringes-recall-mixing-risk-with-human-use. Based on FDA recall #Z-0500-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0500-2020%22&limit=1).

Why it’s dangerous

Syringes labeled 'Posiflush Experimental Product' and 'Not for Human Use' may mix with standard Posif:lush syringes. This could lead to incorrect medical use, potentially causing patient harm if the wrong syringe is used in treatment.

Who’s affected

Healthcare professionals in Canada who use these syringes are most at risk. Patients using the syringes for medical purposes could be affected if the mix-up occurs.

How to tell if you have this one

Check for the label 'Posiflush Experimental Product' and 'Not for Human Use' on the syringe. Affected units have Catalog Number 306575 and Lot Number 9175971 in Canada.

  • Brand
    Becton Dickinson
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Distribution US Nationwide and Canada
Recall numberProduct, codes & lotsQuantity
Z-0499-2020BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306547; Lot Number: 9142881 UDI: 503829030654741,632,000
Z-0500-2020BD Posiflush Pre-Filled Normal Saline Syringes Catalog Number: 306575 (Canada only); Lot Number: 9175971 UDI: 50382903065757967,680
Based on the official FDA remedy

What to do — step by step

  1. Check Syringe Labels

    Look for the label 'Posiflush Experimental Product' and 'Not for Human Use' on the syringe.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Distribution US Nationwide and Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Oct 14, 201912. FDA classified it Class II: Nov 20, 201923. Published in FDA’s Enforcement Report: Nov 27, 201934. FDA terminated the recall: Oct 16, 2020420192020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0500-2020 (October 14, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0500-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA